logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11699503 B1

PDFFull Text
Date of Patent:
Jul. 11, 2023

Filed:

Jan. 19, 2018

Methods of identifying and treating patient populations amenable to cancer immunotherapy

Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Matthew Spitzer, San Francisco, CA (US);

Lawrence Fong, San Francisco, CA (US);

Assignee:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, Oakland, CA (US);

Attorney:

Mintz, Levin, Cohn, Ferris, Glovsk

Primary Examiner:

Vanessa L Ford

Assistant Examiner:

Sandra Carter

Int. Cl.
CPC ...
G16B 25/10 (2019.01); G16B 5/10 (2019.01); G16B 45/00 (2019.01); A61K 38/19 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
G16B 25/10 (2019.02); A61K 38/193 (2013.01); A61K 39/3955 (2013.01); C07K 16/2818 (2013.01); G01N 33/505 (2013.01); G16B 5/10 (2019.02); G16B 45/00 (2019.02); G01N 2333/70596 (2013.01);
Abstract

Methods for identifying cancer patients amenable to anti-cancer immunotherapy are provided along with methods of monitoring cancer therapy. Also provided are methods of treating cancer patients amenable to anti-cancer immunotherapy. The methods involve determining the level of CD127 <low> PD-1 <low> T cells. The patients are treated with an immune checkpoint inhibitor, such as an anti-CTLA-4 antibody, e.g. ipilimumab.

Find Patent Forward Citations

Spitzer, Matthew. (2023). Methods of identifying and treating patient populations amenable to cancer immunotherapy (U.S. Patent No. 11699503). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11699503

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…